John Hart to Liver Cirrhosis
This is a "connection" page, showing publications John Hart has written about Liver Cirrhosis.
Connection Strength
0.713
-
Laser microdissection for gene expression study of hepatocellular carcinomas arising in cirrhotic and non-cirrhotic livers. Methods Mol Biol. 2011; 755:233-44.
Score: 0.325
-
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013 Oct; 33(9):1398-405.
Score: 0.096
-
Genomic and immunophenotypical differences between hepatocellular carcinoma with and without cirrhosis. Histopathology. 2010 May; 56(6):683-93.
Score: 0.078
-
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. Mod Pathol. 2009 Aug; 22(8):1113-20.
Score: 0.073
-
Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am J Surg Pathol. 2004 Mar; 28(3):357-64.
Score: 0.051
-
cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol. 2003 Mar; 162(3):991-1000.
Score: 0.047
-
Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature. Hum Immunol. 2014 Jun; 75(6):578-83.
Score: 0.025
-
Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure. Transplantation. 2009 Apr 27; 87(8):1256-60.
Score: 0.018